Overview
Shilajit is a blackish-brown resinous substance found in high-altitude mountain rocks, particularly the Himalayas, formed over centuries through the decomposition of plant and microbial matter. This mineral-rich compound contains over 85 minerals in ionic form, making it one of nature's most mineral-dense substances. The active compounds in shilajit include fulvic acid (typically 60–80% of the active ingredient), dibenzo-alpha-pyrones, and various humic substances.
Traditionally used in Ayurvedic medicine for centuries, shilajit has gained attention in modern nutritional science as an adaptogen and mitochondrial enhancer. It is primarily studied for its potential to support energy metabolism, cognitive function, testosterone levels, and male fertility. Unlike isolated supplements that target a single pathway, shilajit works through multiple mechanisms simultaneously, making it a comprehensive metabolic support agent.
The supplement is taken orally and is available at an affordable price point, typically ranging from $15 to $55 per month, depending on quality and brand. However, product quality is critical—purified, standardized shilajit from reputable manufacturers carries a reasonable safety profile, while unpurified sources pose significant contamination risks.
Disclaimer: This content is for educational purposes only and should not be construed as medical advice. Always consult a healthcare provider before beginning any new supplement regimen, especially if you have existing health conditions or take medications.
How It Works: Mechanism of Action
Shilajit's effects on human physiology stem from several complementary mechanisms, all centered on enhancing cellular energy production and protecting against oxidative stress.
Mitochondrial Function & ATP Production
The fulvic acid and dibenzo-alpha-pyrones in shilajit function as electron carriers, directly enhancing the activity of mitochondrial Complex I and Complex II. These are crucial enzymes in the electron transport chain responsible for generating ATP—the cell's primary energy currency. By improving electron transfer efficiency through these complexes, shilajit amplifies ATP synthesis, which explains its reputation as a fatigue-fighting supplement.
Additionally, dibenzo-alpha-pyrones help preserve Coenzyme Q10 (CoQ10) in its reduced, active form known as ubiquinol. This is significant because ubiquinol is the electron-carrying form of CoQ10, essential for the electron transport chain's proper function. By preventing CoQ10 oxidation, shilajit indirectly amplifies the already-enhanced mitochondrial function.
Nutrient Transport & Heavy Metal Chelation
Fulvic acid acts as a chelating agent, binding to heavy metals and facilitating their removal from the body. Simultaneously, it enhances nutrient transport across cell membranes, improving the bioavailability of minerals and other nutrients. This dual action means shilajit not only provides 85+ minerals but also helps the body absorb and utilize them more effectively.
Hormonal Modulation & Antioxidant Defense
Shilajit modulates gonadotropin activity, the pituitary hormones that control testosterone production. In animal models, this translates to activation of enzymes like 3β-HSD and 17β-HSD, which are critical in testosterone biosynthesis.
At the cellular level, shilajit reduces oxidative stress by upregulating endogenous antioxidant enzymes—the body's own defense systems. This neuroprotective effect is particularly relevant for brain health and stress resilience.
Evidence by Health Goal
Energy & Fatigue (Tier 3 — Probable Efficacy)
Shilajit shows probable efficacy for energy and fatigue based on human trials, though evidence is limited by small sample sizes and lack of independent replication.
In a human RCT involving 63 recreationally active men, high-dose shilajit (500 mg/day for 8 weeks) significantly reduced fatigue-induced decline in maximal voluntary isometric contraction strength in the upper 50th percentile group. This suggests that individuals with higher baseline strength benefit most from the energizing effects.
Animal studies support the mechanism: in a rat model of chronic fatigue syndrome, shilajit (100 mg/kg) reversed fatigue-induced behavioral deficits, including increased immobility and decreased climbing behavior. Correspondingly, shilajit restored mitochondrial complex chain enzyme activity and mitochondrial membrane potential in the prefrontal cortex, providing mechanistic support for the energy-enhancing effect.
Practical takeaway: Evidence supports shilajit for fatigue reduction, particularly in individuals with baseline physical capacity.
Hormonal Balance & Sexual Health (Tier 2 — Plausible)
While no human clinical trials demonstrate shilajit's effects on testosterone or sexual function, animal models provide compelling mechanistic evidence.
In male mice exposed to cyclophosphamide (a chemotherapy agent that damages sperm production), shilajit at doses of 100–200 mg/kg restored testicular histoarchitecture and improved spermatogonia-to-spermatids conversion. This suggests shilajit may support reproductive health under stress or toxic conditions.
Additionally, in a rat chronic fatigue syndrome model, shilajit (25–100 mg/kg) reversed stress-induced elevations in plasma corticosterone (a primary stress hormone), normalizing HPA axis activity with dose-dependent improvements in behavioral symptoms. Since chronic stress suppresses testosterone, this cortisol-lowering effect indirectly supports hormonal health.
Practical takeaway: Evidence is mechanistic only; human trials are needed to confirm testosterone-supporting benefits.
Cognition & Brain Health (Tier 2 — Plausible)
Shilajit shows promise for cognitive function through mitochondrial support and neuroenergetic mechanisms, though no human cognitive outcome trials exist.
In rats with chronic fatigue syndrome, shilajit reversed behavioral markers of cognitive impairment—increasing climbing behavior and reducing immobility, which are proxy measures of cognitive and motivational capacity. Correspondingly, shilajit increased mitochondrial complex chain enzyme activity (Complex I, II, IV, V) and mitochondrial membrane potential in the rat prefrontal cortex, indicating enhanced neuroenergetics.
One clinical trial in mild Alzheimer's disease patients is mentioned in the literature, but results have not been published in accessible form.
Practical takeaway: The mechanism is sound, but human efficacy data is lacking.
Mood & Stress Management (Tier 2 — Plausible)
Similar to cognition, shilajit demonstrates potential for mood and stress resilience through HPA axis modulation and mitochondrial support, but evidence in humans is absent.
In chronically stressed rats, shilajit (25–100 mg/kg) reversed stress-induced immobility, decreased anxiety in elevated plus maze testing, and normalized prefrontal cortex mitochondrial function. The standardized form used (56.75% fulvic acids, 56.75% dibenzo-α-pyrones) restored complex chain enzyme activity and membrane potential, suggesting that stress-induced mitochondrial dysfunction—a proposed mechanism for depression and anxiety—can be reversed by shilajit.
Practical takeaway: Animal evidence supports an HPA axis and mitochondrial mechanism, but human stress/mood trials are needed.
Sleep (Tier 1 — Insufficient Evidence)
Only a narrative review exists discussing shilajit for high-altitude insomnia. No human trials, animal studies, or mechanistic research on sleep efficacy have been conducted. Claims about sleep improvement remain theoretical.
Practical takeaway: Do not expect sleep improvement based on current evidence.
Skin & Hair Health (Tier 2 — Plausible)
One human RCT demonstrates shilajit's effects on collagen metabolism. In 35 healthy adults, low-dose shilajit (500 mg/day) increased serum pro-c1α1—a biomarker of type I collagen synthesis—by approximately 93.6% over 8 weeks (42.5 → 82.3 ng/mL, p=0.008, effect size d=1.2). High-dose shilajit (1000 mg/day) showed an even larger increase of 164.6% (42.7 → 113.1 ng/mL, p=0.007, d=1.3).
In another RCT involving healthy women, shilajit (250 mg twice daily) improved skin perfusion over 14 weeks and upregulated extracellular matrix (ECM)–related genes in skin tissue, including collagen, elastin, fibronectin, and decorin.
Important note: These studies measured circulating biomarkers and gene expression, not clinical skin or hair improvements. Actual cosmetic outcomes remain unproven.
Practical takeaway: Shilajit likely supports collagen synthesis, but visible skin/hair benefits are not yet clinically validated.
Inflammation & Immune Support (Tier 2 — Plausible)
In mice with acetaminophen-induced liver injury, shilajit pretreatment (0.4–1.6 g/kg) reduced plasma ALT by 75.0% and AST by 69.8%, with modulation of the NF-κB/AKT/Caspase-3 inflammatory axis—a key pathway in inflammation and cell death.
In vitro studies show that fulvic acid fractions from shilajit enhance ROS and nitric oxide production in murine macrophages in a dose-dependent manner and increase lymphocyte proliferation, suggesting immunomodulatory effects.
However, human efficacy trials are absent, and the one RCT examining shilajit (as part of a multi-ingredient formula) did not isolate shilajit's specific immune effects.
Practical takeaway: Animal data is promising, but human immune or inflammation trials do not exist.
Liver Health (Tier 2 — Plausible)
Animal models indicate hepatoprotective effects. In acetaminophen-treated mice, shilajit pretreatment reduced ALT by 75% and AST by 69.8%, suggesting significant protection against liver cell damage.
Critical limitation: No human trials exist; efficacy in humans is entirely unproven.
Heart & Metabolic Health (Tier 2 — Plausible)
Two human RCTs tested shilajit for metabolic markers in the context of exercise and caloric restriction interventions. In a 12-week RCT (n=109) combining shilajit (6 mg) with chromium and phyllanthus emblica in overweight/obese individuals with metabolic syndrome risk factors, metabolic benefits were designed as primary outcomes, but fat loss was not reported.
In a separate 8-week RCT, shilajit (250 mg twice daily) did not alter blood glucose or lipid profiles and was well-tolerated with no adverse effects, though body composition was not measured.
Practical takeaway: Limited human evidence; no direct proof of improved heart health or lipid profiles.
Weight Loss & Fat Loss (Tier 2 — Plausible)
Three human RCTs combined shilajit with exercise and caloric restriction, but none measured fat loss as a primary outcome. The mechanistic plausibility is high—enhanced mitochondrial function and ATP production would theoretically improve metabolic rate and exercise capacity—but direct evidence of weight or fat loss is absent.
Practical takeaway: Shilajit may support metabolism via mitochondrial enhancement, but fat loss has not been proven in humans.
Muscle Growth & Athletic Performance (Tier 2 — Plausible)
One human RCT measured skin gene expression and perfusion rather than muscle mass or strength. Five animal studies suggest potential mechanisms (mitochondrial function, antioxidant activity, testosterone modulation) but do not directly demonstrate muscle hypertrophy.
In rats with chronic fatigue, shilajit reversed immobility and anxiety, suggesting restoration of physical capacity, but this does not directly prove muscle growth in healthy individuals.
Practical takeaway: Mechanism is plausible, but direct evidence of muscle growth is absent.
Injury Recovery (Tier 2 — Plausible)
One human RCT found that shilajit (250 mg twice daily) upregulated 17 extracellular matrix–related gene probe sets in skeletal muscle after 8 weeks, including collagen, elastin, fibronectin, and decorin. Gene expression changes were confirmed by quantitative RT-PCR.
However, no direct efficacy measures for injury recovery (healing speed, pain reduction, or functional restoration) were assessed. Results remain mechanistic rather than clinically validated.
Practical takeaway: Upregulation of structural proteins is promising for tissue repair, but clinical efficacy is unproven.
Longevity (Tier 2 — Plausible)
One human RCT demonstrated improved skin perfusion and upregulation of ECM genes in middle-aged women over 14 weeks. A mechanistic review suggests potential cognitive benefits via fulvic acid's tau-blocking properties (relevant to neurodegeneration), but no direct longevity outcomes have been measured.
Practical takeaway: Plausible mechanism via mitochondrial support and ECM upregulation, but no human longevity data exists.